SCHEMBL7189543

SCHEMBL7189543

[CH2]CNc1ccc([N+](=O)[O-])c(Nc2ccccc2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.56
PIN1 Q13526 1/20 0.51
GSK3A P49840 3/20 0.47
AURKA O14965 2/20 0.47
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
CASP7 P55210 1/20 0.44
MAPT P10636 6/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
LMNA P02545 1/20 0.43
HSF1 Q00613 1/20 0.42
MYC P01106 1/20 0.42
IDO1 P14902 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
BRD4 O60885 2/20 0.41
SIRT5 Q9NXA8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29695661 0.87 GSK3B (0.61) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL11654326 0.82 HSF1 (0.59) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL1600402 0.76 PIN1 (0.65) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL10810171 0.76 GSK3B (0.58) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL2572184 0.76 GSK3B (0.58) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL11834671 0.75 GSK3B (0.65) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL12100934 0.74 GSK3B (0.57) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL4400500 0.74 GSK3B (0.39) GSK3BGSK3AMAPK1ALDH1A1TDP1
SCHEMBL13730151 0.73 GSK3B (0.56) GSK3BPIN1GSK3AAURKAMAPK1
SCHEMBL1601194 0.73 HSF1 (0.52) GSK3BPIN1MAPK1ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317433-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2003-06-11 EP disclosed
WO-2002020495-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2002-03-14 WO disclosed